CRISPR-Cas9 Gene Therapy for Motor Neurone Disease with C9ORF72 Mutations
A gene-editing approach to the most-common genetic cause of MND
Published: 9th March 2021

IP Status
- Know-how based
Seeking
- Development partner
- Commercial partner
- Seeking investment